p53 and its role in the ovarian surface epithelium. A review

The ovarian surface epithelium (OSE) is a single layer of cells subject to a high rate of turnover at he site of follicular rupture at ovulation and this results in a higher risk of malignant cell transformation. Findings like cancer derived from OSE, that accounts for approximately 90% of all human...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2008
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22185
Acceso en línea:
https://repository.urosario.edu.co/handle/10336/22185
Palabra clave:
Cyclin dependent kinase inhibitor 1
Growth arrest and dna damage inducible protein 45
Protein bax
Protein p53
Protein p53
Apoptosis
Cell cycle arrest
Cell structure
Gene mutation
Histogenesis
Human
Ovary cancer
Ovary cell
Pathogenesis
Protein function
Protein stability
Review
Cell differentiation
Cell proliferation
Cytology
Epithelium
Female
Genetics
Metabolism
Ovary
Ovary tumor
Pathology
Physiology
Tumor suppressor gene
Cell differentiation
Cell proliferation
Epithelium
Female
Humans
Ovarian neoplasms
Ovary
Tumor suppressor protein p53
Apoptosis
Cell cycle
Cell signaling
Chemotherapy
Epithelial ovarian cancer
Histogenesis
Pathogenesis
p53
Genes
Rights
License
Abierto (Texto Completo)
Description
Summary:The ovarian surface epithelium (OSE) is a single layer of cells subject to a high rate of turnover at he site of follicular rupture at ovulation and this results in a higher risk of malignant cell transformation. Findings like cancer derived from OSE, that accounts for approximately 90% of all human ovarian malignancies and the frequent mutations of the p53 gen in most of them, are the basis for reviewing OSE structure and histogenesis related to p53, as well as some aspects associated with p53 stabilization and regulation, its involvement in key events like cell cycle arrest, induction of apoptosis, etiology and pathogenesis of epithelial ovarian cancer. Finally, this review takes into account recent farmacogenetics advances in order to use p53 as a target. in the therapy against cancer.